Literature DB >> 17478058

Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.

Jørgen G Bramness1, Hege Kornør.   

Abstract

BACKGROUND: Opioid maintained patients report high levels of anxiety, but the use of benzodiazepines among these patients has been associated with negative outcomes such as increased risk of overdose and death and poorer retention in programmes. Previous research has used interview or urine analysis to assess benzodiazepine use. In this study a prescription database was applied.
METHODS: The Norwegian Prescription Database covers all prescriptions for the entire population from 1 January 2004. Benzodiazepine prescriptions to patients receiving methadone (N=1364) or buprenorphine (N=805) in 2004 and 2005 were studied. Type and amount of drugs received were investigated.
RESULTS: Overall 40% of the patients received at least one prescription for a benzodiazepine drug. Oxazepam was the most frequently prescribed drug. Female patients, methadone-maintained patients and patients in the liberal programmes received a prescription more often. Prescribed doses were high and highest in the liberal programmes. Older patients received more hypnotics. Dose of maintenance drug was positively related to amount of anxiolytics prescribed.
CONCLUSIONS: This study showed that more benzodiazepines were prescribed to opioid maintenance treatment patients than previously shown by investigations using interview or urine analysis. The doses prescribed were generally high. In light of the negative outcomes following benzodiazepine use in these patients, Norwegian doctors need to review their prescription practices.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478058     DOI: 10.1016/j.drugalcdep.2007.03.008

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  21 in total

Review 1.  The pharmacological treatment of opioid addiction--a clinical perspective.

Authors:  Philipp Lobmaier; Michael Gossop; Helge Waal; Jorgen Bramness
Journal:  Eur J Clin Pharmacol       Date:  2010-02-19       Impact factor: 2.953

2.  Concurrent Use of Benzodiazepine by Heroin Users-What Are the Prevalence and the Risks Associated with This Pattern of Use?

Authors:  T Yamamoto; P I Dargan; A Dines; C Yates; F Heyerdahl; K E Hovda; I Giraudon; R Sedefov; D M Wood
Journal:  J Med Toxicol       Date:  2018-07-31

3.  Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine.

Authors:  Michelle R Lofwall; Jennifer R Havens
Journal:  Drug Alcohol Depend       Date:  2012-06-15       Impact factor: 4.492

4.  Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.

Authors:  Tae Woo Park; Marc R Larochelle; Richard Saitz; Na Wang; Dana Bernson; Alexander Y Walley
Journal:  Addiction       Date:  2020-01-20       Impact factor: 6.526

5.  High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City.

Authors:  Pedro Mateu-Gelabert; Lauren Jessell; Elizabeth Goodbody; Dongah Kim; Krista Gile; Jennifer Teubl; Cassandra Syckes; Kelly Ruggles; Jeffrey Lazar; Sam Friedman; Honoria Guarino
Journal:  Int J Drug Policy       Date:  2017-05-31

6.  Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes.

Authors:  Zev Schuman-Olivier; Bettina B Hoeppner; Roger D Weiss; Jacob Borodovsky; Howard J Shaffer; Mark J Albanese
Journal:  Drug Alcohol Depend       Date:  2013-05-18       Impact factor: 4.492

Review 7.  Polydrug abuse: a review of opioid and benzodiazepine combination use.

Authors:  Jermaine D Jones; Shanthi Mogali; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-08-02       Impact factor: 4.492

8.  Reduction in mental distress among substance users receiving inpatient treatment.

Authors:  Ellen Hoxmark; Vår Benum; Oddgeir Friborg; Rolf Wynn
Journal:  Int J Ment Health Syst       Date:  2010-12-02

9.  Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?

Authors:  Vivian Y O Au; Tea Rosic; Nitika Sanger; Alannah Hillmer; Caroul Chawar; Andrew Worster; David C Marsh; Lehana Thabane; Zainab Samaan
Journal:  Harm Reduct J       Date:  2021-07-08

10.  Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study.

Authors:  Pekka Rapeli; Carola Fabritius; Hely Kalska; Hannu Alho
Journal:  Subst Abuse Treat Prev Policy       Date:  2012-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.